AbCellera to Present at Upcoming Investor Conferences in December and January
AbCellera (ABCL) has announced its participation in two major upcoming investor conferences. The company will present at the Piper Sandler 36th Annual Healthcare Conference in New York on December 3, 2024, at 11:30 a.m. PT, and at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2025, at 4:30 p.m. PT.
Both presentations will be accessible via live audio webcasts through links on AbCellera's Investor Relations website, with replay options available after the events.
AbCellera (ABCL) ha annunciato la sua partecipazione a due importanti conferenze per investitori. L'azienda presenterà alla 36ª Conferenza Annuale sulla Salute di Piper Sandler a New York il 3 dicembre 2024, alle 11:30 PT, e alla 43ª Conferenza Annuale sulla Salute di J.P. Morgan a San Francisco il 15 gennaio 2025, alle 16:30 PT.
Entrambe le presentazioni saranno accessibili tramite webcast audio in diretta tramite collegamenti sul sito web delle Relazioni con gli Investitori di AbCellera, con opzioni di replica disponibili dopo gli eventi.
AbCellera (ABCL) ha anunciado su participación en dos importantes conferencias de inversores. La compañía presentará en la 36ª Conferencia Anual de Salud de Piper Sandler en Nueva York el 3 de diciembre de 2024, a las 11:30 a.m. PT, y en la 43ª Conferencia Anual de Salud de J.P. Morgan en San Francisco el 15 de enero de 2025, a las 4:30 p.m. PT.
Ambas presentaciones estarán accesibles a través de transmisiones web de audio en vivo mediante enlaces en el sitio web de Relaciones con Inversores de AbCellera, con opciones de reproducción disponibles después de los eventos.
AbCellera (ABCL)는 두 가지 주요 투자자 회의에 참석할 것이라고 발표했습니다. 이 회사는 2024년 12월 3일 뉴욕에서 오전 11시 30분 PT에 파이퍼 샌들러 제36회 연례 헬스케어 회의에서 발표할 예정이며, 2025년 1월 15일 샌프란시스코에서 오후 4시 30분 PT에 JP 모건 제43회 연례 헬스케어 회의에서도 발표할 예정입니다.
두 발표 모두 AbCellera의 투자자 관계 웹사이트의 링크를 통해 생중계 오디오 웹캐스트를 통해 접근 가능하며, 이벤트 후 재생 옵션도 제공됩니다.
AbCellera (ABCL) a annoncé sa participation à deux grandes conférences pour investisseurs. La société présentera à la 36e Conférence Annuelle sur la Santé de Piper Sandler à New York le 3 décembre 2024 à 11h30 PT, et à la 43e Conférence Annuelle sur la Santé de J.P. Morgan à San Francisco le 15 janvier 2025 à 16h30 PT.
Les deux présentations seront accessibles via des webcasts audio en direct via des liens sur le site Web des Relations Investisseurs d'AbCellera, avec des options de rediffusion disponibles après les événements.
AbCellera (ABCL) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen angekündigt. Das Unternehmen wird am 3. Dezember 2024 um 11:30 Uhr PT auf der 36. jährlichen Healthcare-Konferenz von Piper Sandler in New York und am 15. Januar 2025 um 16:30 Uhr PT auf der 43. jährlichen Healthcare-Konferenz von J.P. Morgan in San Francisco präsentieren.
Beide Präsentationen werden über Live-Audio-Webcasts, die über Links auf der Investor-Relations-Website von AbCellera zugänglich sind, verfügbar sein, mit Replay-Optionen, die nach den Veranstaltungen bereitgestellt werden.
- None.
- None.
-
Piper Sandler 36th Annual Healthcare Conference in
New York, NY on Tuesday, December 3, 2024, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) -
43rd Annual J.P. Morgan Healthcare Conference in
San Francisco, CA on Wednesday, January 15, 2025, at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time)
Live audio webcasts of the presentation may be accessed through the link that will be posted on AbCellera's Investor Relations website. Replays of the webcast will be available through the same links following the presentations.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241121268256/en/
Inquiries
Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005
Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116
Source: AbCellera Biologics Inc.
FAQ
When is AbCellera (ABCL) presenting at the Piper Sandler Healthcare Conference 2024?
When is AbCellera (ABCL) presenting at the J.P. Morgan Healthcare Conference 2025?
How can I watch AbCellera's (ABCL) investor conference presentations?
Which investor conferences is AbCellera (ABCL) attending in 2024-2025?
